Logo image
Assessment of CD38 brightHLA-DR+ T cells using a rapid flow cytometry-based assay to aid in the diagnosis of Hemophagocytic Lymphohistiocytosis and Immune regulatory disorders in adult subjects
Journal article   Open access   Peer reviewed

Assessment of CD38 brightHLA-DR+ T cells using a rapid flow cytometry-based assay to aid in the diagnosis of Hemophagocytic Lymphohistiocytosis and Immune regulatory disorders in adult subjects

Aaruni Khanolkar, Erin Weyers, Ramakrishna Sompallae and Matthew D Krasowski
Clinical immunology communications, Vol.8, pp.1-5
12/2025
DOI: 10.1016/j.clicom.2025.05.004
url
https://doi.org/10.1016/j.clicom.2025.05.004View
Published (Version of record) Open Access

Abstract

Rapid and accurate diagnosis of patients suspected of suffering from hyperinflammatory conditions such as hemophagocytic lymphohistiocytosis (HLH) is a critical aspect of timely management for such disorders. Soluble IL-2Rα (sIL-2Rα) and plasma ferritin constitute the mainstay of frontline laboratory investigations performed to establish a clinical diagnosis for these patients. However, there is a paucity of clinical laboratories that perform the sIL-2Rα measurement as a stat test which can delay the diagnosis and management of these patients. Consequently, rapid flow cytometry-based tests that measure T cell activation are currently being evaluated. Previous studies have examined the utility of flow-cytometry based testing in pediatric subjects with HLH and immune dysregulation disorders. In this report, we assessed the utility of our flow-cytometry based test in adult patients suspected of HLH and discuss its performance in relation to what has been reported previously in the literature for pediatric patients.
Allergy and Immunology

Details

Metrics

20 Record Views
Logo image